IFNG and cancer: In diverse cancer lineages (colon and lung cancer, melanoma, and leukemia), the synergistic action of TNF-α and IFN-γ can trigger the activation of a variety of signaling switches such as GSDMD, GSDME, caspase-8, and MLKL.